![Rasmus Holm-Jorgensen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rasmus Holm-Jorgensen
Geen lopende functies
Vermogen: 41 741 $ op 31-05-2026
Profiel
Mr. Rasmus Holm-Jorgensen was previously employed as a Chief Financial Officer by Acrivon Therapeutics, Inc., a Chief Strategy & Portfolio Officer by Kiniksa Pharmaceuticals Ltd., and a Group Vice President & General Manager by Synageva BioPharma Corp.
He received his graduate degree from the University of Copenhagen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2025 | 26.088 ( 0,06% ) | 41 741 $ | 31-05-2026 |
Eerdere bekende functies van Rasmus Holm-Jorgensen
| Bedrijven | Functie | Einde |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-04-2025 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Oprichter | 01-04-2022 |
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 01-01-2015 |
Opleiding van Rasmus Holm-Jorgensen
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
28
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Kies MarketScreener 
